Short Term Culture of Human Mesenchymal Stem Cells with Commercial Osteoconductive Carriers Provides Unique Insights into Biocompatibility
For spinal fusions and the treatment of non-union fractures, biological substrates, scaffolds, or carriers often are applied as a graft to support regeneration of bone. The selection of an appropriate material critically influences cellular function and, ultimately, patient outcomes. Human bone marr...
Main Authors: | Matthew B. Murphy, Richard K. Suzuki, Theodore T. Sand, Christopher D. Chaput, Carl A. Gregory |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2077-0383/2/3/49 |
Similar Items
-
The Osteogenic Potential of Human Non-differentiated and Pre-differentiated Mesenchymal Stem Cells Combined with an Osteoconductive Scaffold – Early Stage Healing
by: Luboš Tuček, et al.
Published: (2017-06-01) -
Demographic variation in bone-marrow derived mesenchymal stem cell analytes
by: Dunlap, Margaret
Published: (2021) -
Controlled aggregation enhances immunomodulatory potential of mesenchymal stromal cell aggregates
by: Angela W. Xie, et al.
Published: (2021-08-01) -
An Osteoconductive Antibiotic Bone Eluting Putty with a Custom Polymer Matrix
by: John Curley, et al.
Published: (2016-06-01) -
TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2−/−-Driven Myeloid Malignancy Progression
by: Rong Li, et al.
Published: (2018-01-01)